Hypofractionated concurrent chemoradiation in non-small cell lung cancer (NSCLC): efficacy and toxicity of the SOCCAR trial regime in real world practice

被引：1
|
作者：
Iqbal, M. S. [1 ]
Vashisht, G. [2 ]
Mulvenna, P. [1 ]
McDonald, F. [1 ]
Turnbull, H. [1 ]
Atherton, P. [1 ]
Bradshaw, A. [1 ]
Simmons, T. [3 ]
Kovarik, J. [1 ]
Singhal, S. [1 ]
McMenemin, R. [3 ]
Greystoke, A. [4 ]
机构：
[1] Northern Ctr Canc Care, Clin Oncol, Newcastle Upon Tyne, Tyne & Wear, England
[2] Newcastle Univ, Med Sch, HH, Newcastle Upon Tyne, Tyne & Wear, England
[3] Freeman Rd Hosp, NCCC, Clin Oncol, Newcastle Upon Tyne, Tyne & Wear, England
[4] NCCC, Med Oncol, Newcastle Upon Tyne, Tyne & Wear, England
来源：
LUNG CANCER | 2018年 / 115卷
关键词：
D O I：
10.1016/S0169-5002(18)30175-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
149
引用
收藏
页码：S64 / S64
页数：1
相关论文
共 50 条
  • [21] Radical concurrent chemoradiotherapy (CRT) for non-small cell lung cancer (NSCLC)
    Stilwell, C. H.
    Shrimali, R. K.
    Sharma, R. N.
    Nicolson, M. C.
    Steven, E.
    Bissett, J. D.
    LUNG CANCER, 2013, 79 : S62 - S63
  • [22] Overcoming toxicity-challenges in chemoradiation for non-small cell lung cancer
    Uyterlinde, Wilma
    TRANSLATIONAL LUNG CANCER RESEARCH, 2016, 5 (03) : 239 - 243
  • [23] Non-small Cell Lung Cancer (NSCLC) in Octogenarians in Clinical Practice
    Koyi, Hirsh
    Hillerdal, Gunnar
    Kolbeck, Karl-Gustav
    Brodin, Daniel
    Liv, Per
    Branden, Eva
    ANTICANCER RESEARCH, 2016, 36 (10) : 5397 - 5402
  • [24] An audit comparing two different cisplatin schedules and subsequent nephrotoxicity for two different schedules used in concurrent chemoradiation: Sequential Or Concurrent Chemotherapy And Radiotherapy (SOCCAR) regime for inoperable non-small cell lung cancer
    Wakeham, K.
    Jones, R.
    Brisbane, I.
    Roxburgh, P.
    MacPhee, J.
    Hicks, J.
    LUNG CANCER, 2014, 83 : S7 - S7
  • [25] Chemoradiation in older patients with stage III non-small cell lung cancer (NSCLC)
    Ng, Dawn M.
    Sun, Alex
    Coate, Linda
    Ma, Clement
    Bezjak, Andrea
    Brade, Anthony
    Burkes, Ronald L.
    Cho, John
    Feld, Ronald
    Liu, Geoff
    Shepherd, Frances
    Leighl, Natasha B.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S858 - S858
  • [26] Update on real-world efficacy of anlotinib in non-small cell lung cancer
    Gao, Junzhen
    Xu, Yan
    Liu, Yonggang
    Liang, Li
    Yu, Yan
    Zhao, Dahai
    Jin, Jiahui
    Wang, Mengzhao
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [27] Outcome of Concurrent Chemoradiation Therapy for Stage III Non-Small Cell Lung Cancer
    Liu, L.
    Ji, Z.
    Cao, J.
    Wang, J.
    Hui, Z.
    Liang, J.
    Wang, X.
    Lv, J.
    Wang, L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S648 - S648
  • [28] Induction Concurrent Chemoradiation Therapy for Invading Apical Non-Small Cell Lung Cancer
    Miyoshi S.
    Iuchi K.
    Nakamura K.
    Nakagawa K.
    Maeda H.
    Ohno K.
    Nakahara K.
    Nakano N.
    Okumura M.
    Ohta M.
    The Japanese Journal of Thoracic and Cardiovascular Surgery, 2004, 52 (3) : 120 - 126
  • [29] Clinical Responses and Prognostic Indicators of Concurrent Chemoradiation for Non-small Cell Lung Cancer
    Lee, Dong-Soo
    Kim, Yeon-Sil
    Kang, Jin-Hyoung
    Lee, Sang-Nam
    Kim, Young-Kyoun
    Ahn, Myung-Im
    Han, Dae-Hee
    Yoo, Ie-Ryung
    Wang, Young-Pil
    Park, Jae-Gil
    Yoon, Sei-Chul
    Jang, Hong-Seok
    Choi, Byung-Oak
    CANCER RESEARCH AND TREATMENT, 2011, 43 (01): : 32 - 41
  • [30] Comparison between concurrent and sequential chemoradiation for non-small cell lung cancer in vitro
    Song, Seo-Young
    Das, Amit K.
    Minna, John D.
    ONCOLOGY LETTERS, 2014, 7 (02) : 307 - 310
12345